Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · IEX Real-Time Price · USD
3.200
+0.030 (0.95%)
At close: Mar 28, 2024, 3:58 PM
3.040
-0.160 (-5.00%)
After-hours: Mar 28, 2024, 7:55 PM EDT

Cyclerion Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Cash & Equivalents
7.5713.3853.9654.494.9000
Cash & Cash Equivalents
7.5713.3853.9654.494.9000
Cash Growth
-43.42%-75.20%-0.80%-42.68%----
Receivables
00.10.10.131.47000
Other Current Assets
0.451.341.43.984.830.881.260.28
Total Current Assets
8.0214.8255.4658.5101.20.881.260.28
Property, Plant & Equipment
01.221.4750.2779.756.54.133.6
Long-Term Investments
5.35003.844.99000
Other Long-Term Assets
02.042.412.770.540.030.080
Total Long-Term Assets
5.353.263.8756.8885.286.524.213.6
Total Assets
13.3718.0859.33115.38186.487.45.473.88
Accounts Payable
1.22.971.831.443.312.781.81.41
Current Debt
0006.83.42000
Other Current Liabilities
0.894.669.268.7211.5215.0712.249.23
Total Current Liabilities
2.097.6311.0916.9518.2517.8514.0410.64
Long-Term Debt
00038.9370.5000
Total Long-Term Liabilities
00038.9370.5000
Total Liabilities
2.097.6311.0955.8988.7517.8514.0410.64
Total Debt
00045.7473.92000
Debt Growth
----38.13%----
Retained Earnings
-264.42-259.15-215.08-163.43-85.630--
Comprehensive Income
-0.01-0.02-0.02-0.03-0.02000
Shareholders' Equity
11.2910.4548.2559.4997.73-10.45-8.57-6.76
Net Cash / Debt
7.5713.3853.968.6620.98000
Net Cash / Debt Growth
-43.42%-75.20%523.11%-58.71%----
Net Cash Per Share
3.246.16------
Working Capital
5.947.1944.3741.5582.95-16.97-12.78-10.36
Book Value Per Share
4.834.8122.2835.0371.16-13.43--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).